Related references
Note: Only part of the references are listed.Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Michael K. Gould et al.
CHEST (2012)
Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
G. Cullen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2011)
Long-term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2011)
Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism
Gottfried Novacek et al.
GASTROENTEROLOGY (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
Clinical relevance of changes in bone metabolism in inflammatory bowel disease
Pal Miheller et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?
Sunny Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Mucocutaneous Manifestations in Inflammatory Bowel Disease
Ilhami Yueksel et al.
INFLAMMATORY BOWEL DISEASES (2009)
Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis
Fabiola Atzeni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases - A cohort study of 2402 patients
David Farhi et al.
MEDICINE (2008)
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy
Pal Miheller et al.
INFLAMMATORY BOWEL DISEASES (2007)
Extraintestinal manifestations of Crohn's disease
Pascal Juillerat et al.
DIGESTION (2007)
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation
Anat Galor et al.
OPHTHALMOLOGY (2006)
Treatment of chronic erythema nodosum with infliximab
T. H. Clayton et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
J Zochling et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn et al.
GUT (2006)
Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take toll?
Peter Laszlo Lakatos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease
S Henderson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease
M Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The effect of infliximab on extraintestinal manifestations of Crohn's disease
I Kaufman et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia
L Spina et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
W Miehsler et al.
GUT (2004)
Ocular manifestations of inflammatory bowel disease
R Mintz et al.
INFLAMMATORY BOWEL DISEASES (2004)
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
S Generini et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
AGA technical review on osteoporosis in gastrointestinal diseases
CN Bernstein et al.
GASTROENTEROLOGY (2003)
Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
TR Orchard et al.
GASTROENTEROLOGY (2002)
Pyoderma gangrenosum associated with Crohn disease:: effect of TNF-α blockade with infliximab
T Ljung et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions
ML Bennett et al.
MEDICINE (2000)
Share Paper
